Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma
© 2016 by the American Association for the Study of Liver Diseases Angiogenesis inhibition by the vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) inhibitor sorafenib provides survival benefit in hepatocellular carcinoma (HCC); however, angiogen...
Saved in:
Main Authors: | Ann Lii Cheng, Sumitra Thongprasert, Ho Yeong Lim, Wattana Sukeepaisarnjaroen, Tsai Shen Yang, Cheng Chung Wu, Yee Chao, Stephen L. Chan, Masatoshi Kudo, Masafumi Ikeda, Yoon Koo Kang, Hongming Pan, Kazushi Numata, Guohong Han, Binaifer Balsara, Yong Zhang, Ana Marie Rodriguez, Yi Zhang, Yongyu Wang, Ronnie T.P. Poon |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84987909452&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/56247 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma
by: Cheng A., et al.
Published: (2017) -
Training for frontliners in the hotels
by: Lee, Tein Ne, et al.
Published: (2015) -
Chinese Fishermen at Frontline of Maritime Disputes: An Alternative Explanation
by: Zhang, Hongzhou
Published: (2016) -
‘Labouring’ on the frontlines of global health research: mapping challenges experienced by frontline workers in Africa and Asia
by: Nkosi B.
Published: (2023) -
Health Workers on the Political Frontlines
by: Lasco, Gideon
Published: (2022)